Synonyms
Definition
The flavonoids are a group of plant secondary metabolites biosynthetically derived from shikimic acid and polyketide pathways. They are plant pigments containing benzopyrone substituted with a phenyl ring at position 2 or 3 and possess a wide spectrum of biological activities, including antioxidant and anti-inflammatory activities.
Chemical Structures and Properties
The technical term “flavonoid” arises from the basic skeleton of these plant pigments that are derived from benzo-γ-pyrone, structure well known as chromone, modified at position 2 or 3 by the addition of a phenyl ring at position 2 yielding a flavonoid and at position 3 an isoflavonoid (Fig. 1). The biosynthesis of flavonoids is based on the crossing of shikimic acid and acylphloroglucinol metabolic pathways. The three-ring skeleton may be substituted with hydroxyl groups. Substitution of the A ring typically occurs at positions 5 and 7 (a meta...
References
Bruneton, J. (1999). Pharmacognosy, phytochemistry, medicinal plants. Lavoisier, Paris, France.
Costa, G., Francisco, V., Lopes, M. C., Cruz, M. T., & Batista, M. T. (2012). Intracellular signaling pathways modulated by phenolic compounds: Application for new anti-inflammatory drugs discovery. Current Medicinal Chemistry, 19, 2876–2900.
Crozier, A., Del Rio, D., & Clifford, M. N. (2010). Bioavailability of dietary flavonoids and phenolic compounds. Molecular Aspects of Medicine, 31, 446–467.
de Pascual-Teresa, S., Moreno, D. A., & García-Viguera, C. (2010). Flavanols and anthocyanins in cardiovascular health: A review of current evidence. International Journal of Molecular Science, 11, 1679–1703.
Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013). Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects again chronic diseases. Antioxidants & Redox Signaling, 18, 1818–1892.
Dolton, M. J., Roufogalis, B. D., & McLachlan, A. J. (2012). Fruit juices as perpetrators of drug interactions: The role of organic anion-transporting polypeptides. Clinical Pharmacology & Therapeutics, 92, 622–630.
Egert, S., & Rimbach, G. (2011). Which sources of flavonoids: Complex diets or dietary supplements? Advances in Nutrition, 2. doi:10.3945/an.110.000026.
García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M. A., & Martínez, J. A. (2009). Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflammation Research, 58, 537–552.
Hamer, M., & Steptoe, A. (2006). Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: A systematic review. British Journal of Nutrition, 95, 849–859.
Havsteen, B. H. (2002). The biochemistry and medical significance of the flavonoids. Pharmacology & Therapeutics, 96, 67–202.
Izzi, V., Masuelli, l., Tresoldi, I., Sacchetti, P., Modesti, A., Galvano, F., & Bei, R. (2012). The effects of dietary flavonoids on the regulation of redox inflammatory networks. Frontiers in Bioscience, 17, 2396–2418.
Kim, P. K., Son, K. H., Chang, H. W., & Kang, S. S. (2004). Anti-inflammatory plant flavonoids and cellular action mechanisms. Journal of Pharmacological Sciences, 96, 229–245.
Peterson, J., & Dwyer, J. (1998). Flavonoids: Dietary occurrence and biochemical activity. Nutrition Research, 18, 1995–2018.
Pietta, P. G. (2000). Flavonoids as antioxidants. Journal of Natural Products, 63, 1035–1042.
Procházková, D., Boušová, I., & Wilhelmová, N. (2011). Antioxidant and prooxidant properties of flavonoids. Fitoterapia, 82, 513–523.
Seden, K., Dickinson, L., Khoo, S., & Back, D. (2010). Grapefruit-drug interactions. Drugs, 70, 2373–2407.
Skibola, C. F., & Smith, M. T. (2000). Potential health impacts of excessive flavonoid intake. Free Radical Biology and Medicine, 29, 375–383.
Smejkal, K. (2014). Cytotoxic potential of C-prenylated flavonoids. Phytochemistry Reviews, 13, 245–275.
Srinivas, N. R. (2013). Is pomegranate juice a potential perpetrator of clinical drug-drug interactions? Review of the in vitro, preclinical and clinical evidence. European Journal of Drug Metabolism and Pharmacokinetics, 38, 223–229.
Thilakarathna, S. H., & Rupasinghe, H. P. V. (2013). Flavonoids bioavailability and attempts for bioavailability enhancement. Nutrients, 5, 3367–3387.
Yazaki, K., Sasaki, K., & Tsurumaru, Y. (2009). Prenylation of aromatic compounds, a key diversification of plant secondary metabolites. Phytochemistry, 70, 1739–1745.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Basel
About this entry
Cite this entry
Hošek, J., Šmejkal, K. (2015). Flavonoids as Anti-inflammatory Agents. In: Parnham, M. (eds) Encyclopedia of Inflammatory Diseases. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-0620-6_19-1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0620-6_19-1
Received:
Accepted:
Published:
Publisher Name: Birkhäuser, Basel
Online ISBN: 978-3-0348-0620-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences